To further examine the inhibitory effect of drug FHND004 on the proliferation of MM cells through targeting PBK, we constructed ARP1 and H929 cells with stable PBK overexpressing (PBK-OE), which was verified by WB (Figure 6A and quantified in Supplementary Figure 2, A). This evidence concerns the gene PBK and Miyoshi myopathy.